Robert E. Ward
Direktor/Vorstandsmitglied bei Massachusetts High Technology Council, Inc.
Aktive Positionen von Robert E. Ward
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Massachusetts High Technology Council, Inc.
Massachusetts High Technology Council, Inc. Internet Software/ServicesTechnology Services Massachusetts High Technology Council is an organization that advocates for public policies and programs that create and maintain a competitive business climate. The non-profit company is based in Waltham, MA. The company has been nurturing tech companies for over 70 years, despite its reputation as a high-tax expensive place to do business. The Massachusetts High Technology Council provides resources and hosts events for its members, and offers membership to organizations that want to join other thought leaders in the Commonwealth. Massachusetts High Technology Council Member Testimonials are available on their website. The company was founded by Raymond S. Stata. | Direktor/Vorstandsmitglied | - | - |
Antidote Therapeutics, Inc.
Antidote Therapeutics, Inc. BiotechnologyHealth Technology Antidote Therapeutics, Inc. engages in the provision of nicotine-blocking drugs to treat diseases caused or worsened by nicotine. Its product pipeline include ATI-1013, ATI 3009, and ATI-2000. The company was founded by Matthew Kalnik and is headquartered in Gaithersburg, MD. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Robert E. Ward
Ehemalige bekannte Positionen von Robert E. Ward
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ONCOSEC MEDICAL INCORPORATED | Direktor/Vorstandsmitglied | 08.11.2018 | 23.11.2021 |
Independent Dir/Board Member | 08.11.2018 | 23.11.2021 | |
ELOXX PHARMACEUTICALS, INC. | Vorstandsvorsitzender | 26.12.2017 | 29.02.2020 |
Vorsitzender | 26.12.2017 | 29.02.2020 | |
AKARI THERAPEUTICS, PLC | Direktor/Vorstandsmitglied | 14.10.2016 | 01.08.2018 |
Independent Dir/Board Member | 14.10.2016 | 01.08.2018 | |
RADIUS HEALTH, INC. | Direktor/Vorstandsmitglied | 16.12.2013 | 17.07.2017 |
Vorstandsvorsitzender | 16.12.2013 | 17.07.2017 | |
Präsident | 16.12.2013 | 17.07.2017 | |
ASTRAZENECA PLC | Corporate Officer/Principal | 01.01.2011 | 01.12.2013 |
Harriman Biopartners LLC | Corporate Officer/Principal | 01.01.2010 | 01.01.2011 |
NPS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.01.2006 | 01.01.2010 |
░░░░░░░░ ░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | - | - |
Ausbildung von Robert E. Ward
University of California, Santa Barbara | Undergraduate Degree |
New Jersey Institute of Technology | Graduate Degree |
The Johns Hopkins University School of Medicine | Graduate Degree |
Statistik
International
Vereinigte Staaten | 12 |
Vereinigtes Königreich | 3 |
Operativ
Director/Board Member | 5 |
Corporate Officer/Principal | 3 |
Chief Executive Officer | 2 |
Sektoral
Health Technology | 7 |
Consumer Services | 4 |
Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 5 |
---|---|
ASTRAZENECA PLC | Health Technology |
ONCOSEC MEDICAL INCORPORATED | Health Services |
CLARKSON PLC | Transportation |
AKARI THERAPEUTICS, PLC | Health Technology |
ELOXX PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 5 |
---|---|
NPS Pharmaceuticals, Inc.
NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NPS Pharmaceuticals, Inc. developed drugs for bone and mineral disorders. It also developed Natpara for the treatment of adult hypoparathyroidism. The company was founded by Hunter Jackson and Thomas N. Parks on October 22, 1986 and is headquartered in Bedminster, NJ. | Health Technology |
Radius Health, Inc.
Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
Massachusetts High Technology Council, Inc.
Massachusetts High Technology Council, Inc. Internet Software/ServicesTechnology Services Massachusetts High Technology Council is an organization that advocates for public policies and programs that create and maintain a competitive business climate. The non-profit company is based in Waltham, MA. The company has been nurturing tech companies for over 70 years, despite its reputation as a high-tax expensive place to do business. The Massachusetts High Technology Council provides resources and hosts events for its members, and offers membership to organizations that want to join other thought leaders in the Commonwealth. Massachusetts High Technology Council Member Testimonials are available on their website. The company was founded by Raymond S. Stata. | Technology Services |
Harriman Biopartners LLC | |
Antidote Therapeutics, Inc.
Antidote Therapeutics, Inc. BiotechnologyHealth Technology Antidote Therapeutics, Inc. engages in the provision of nicotine-blocking drugs to treat diseases caused or worsened by nicotine. Its product pipeline include ATI-1013, ATI 3009, and ATI-2000. The company was founded by Matthew Kalnik and is headquartered in Gaithersburg, MD. | Health Technology |
- Börse
- Insiders
- Robert E. Ward
- Erfahrung